Si-Bone Inc (SIBN)
SI-BONE, Inc. is a medical device company focused on procedural solutions for compromised bone in the United States and international markets. The company develops and markets patented titanium implants, related surgical instruments, and implantable bone products designed for orthopedic and sacroiliac joint applications. Its product portfolio includes the iFuse family, such as iFuse, iFuse 3D, iFuse Bone, iFuse TORQ, iFuse Bedrock Granite, and iFuse TORQ TNT, each engineered for different fusion, fixation, or bone-support uses. SI-BONE sells primarily through a direct sales force, supplemented by third-party sales agents and resellers. Incorporated in 2008, the company is headquartered in Santa Clara, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SIBN
|
$15.35
|
-18.4% Downside
|
Overvalued
|
$25
|
32.9% Upside
|
Undervalued
|
Good
|
0.0%
|
November 9, 2026
|
4.6x
|
3.9x
|
843 M
|
739.9 M
|
4.9%
|
89.2%
|
6.5
|
30.0%
|
